Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Jul-Aug;8(5):535-538.
Epub 2017 Jul 1.

Use of Atezolizumab for Bladder and Non-Small Cell Lung Cancers

Kayla Faith Moore  1
Affiliations
Review

Use of Atezolizumab for Bladder and Non-Small Cell Lung Cancers

Kayla Faith Moore. J Adv Pract Oncol. 2017 Jul-Aug.
No abstract available

PubMed Disclaimer

Figures

Table
Table
Dosage and Administration of Atezolizumab
See this image and copyright information in PMC

References

    1. American Cancer Society. Atlanta, Ga: American Cancer Society; 2016. American Cancer Society: Cancer Facts and Figures 2016. . Retrieved from http://www.cancer.org/acs/groups/content/@research/documents/document/ac....
    1. Horn L, Spigel D R, Gettinger S N, Antonia S J, Gordon M S, Herbst R S, Soria J C. Clinical activity, safety and predictive biomarkers of the engineered antibody MPDL3280A (anti-PDL1) in non-small cell lung cancer: Update from a phase Ia study [Abstract 8029]. 2015 ASCO Annual Meeting. 2015;33 Retrieved from http://meetinglibrary.asco.org/record/108531/abstract .
    1. Howlader N, Noone A M, Krapcho M, Miller D, Bishop K, Altekruse S F, Cronin K A, editors. (April 2016). SEER Cancer Statistics Review, 1975-2013, National Cancer Institute. Bethesda, MD. . 2016 Retrieved from http://seer.cancer.gov/csr/1975_2013/ based on November 2015 SEER data submission, posted to the SEER Website .
    1. Petrylak D P, Powles T, Bellmunt J, Braiteh F S, Loriot Y, Zambrano C C, Vogelzang N J. A phase Ia study of MPDL3280A (anti-PDL1): Updated response and survival data in urothelial bladder cancer [Abstract 4501]. 2015 ASCO Annual Meeting . 2015;33 Retrieved from http://meetinglibrary.asco.org/record/109709/abstract.
    1. Powles Thomas, Eder Joseph Paul, Fine Gregg D, Braiteh Fadi S, Loriot Yohann, Cruz Cristina, Bellmunt Joaquim, Burris Howard A, Petrylak Daniel P, Teng Siew-leng, Shen Xiaodong, Boyd Zachary, Hegde Priti S, Chen Daniel S, Vogelzang Nicholas J. MPDL3280A (anti-PD-L1) treatment leads to clinical activity in metastatic bladder cancer. Nature. 2014;515:558–562. - PubMed

LinkOut - more resources